Pharmafile Logo
Pharmafocus logo
Advanced Search
Shire image

Shire to buy Meritage Pharma

February 25, 2015
Research and Development, Sales and Marketing AbbVie, Meritage Pharma, Shire, eoe, gastrointestinal

Shire has purchased Meritage Pharma, a privately-held company specialising in gastrointestinal and skin diseases for $70 million. The acquisition means …

News
Avastin image

Doctors appeal to prescribe Avastin off-label

February 25, 2015
Sales and Marketing Lucentis, NHS, NICE, Novartis, Roche, bevacizumab, wet AMD

NHS Clinical Commissioners have called for the removal of barriers preventing CCGs from prescribing Roche’s Avastin to treat wet age-related …

News

FDA in Novartis cancer drug U-turn

February 24, 2015
Research and Development, Sales and Marketing Cancer, FDA, Farydak, Novartis, Revlimid, Velcade, myeloma

The FDA has overturned an earlier advisory committee recommendation and decided to approve Novartis’ blood cancer drug Farydak. In November …

News
Takeda image

Takeda acquires Turkish firm Neutec

February 24, 2015
Sales and Marketing Takeda, Turkey, gastroenterology, neutec, respiratory, turkish

Takeda has signed an agreement to acquire one of Turkey’s leading pharma firms Neutec in a $120 million deal. The …

News
Isentress image

Merck puts HIV drug in shared patent pool

February 24, 2015
Research and Development, Sales and Marketing AbbVie, Gilead, HIV, Merck, Raltegravir, Roche, isentress

Merck is teaming up with the Medicines Patent Pool (MPP) to license its paediatric HIV treatment in developing countries. The …

News
QELFA device

Novel device could help fight kidney disease

February 24, 2015
Research and Development, Sales and Marketing Bio Nano Consulting, Pfizer, QELFA, Rapamune, device, ime, kidney

A novel device that combines nanotechnology and a pregnancy tester could help treat kidney disease, according to a report by …

News
BMS image

BMS in $1.5 billion immuno-oncology expansion

February 24, 2015
Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, Rigel, flexus, immuno-oncology

Bristol-Myers Squibb has confirmed two major deals to enhance the company’s standing in the immuno-oncology field. The first agreement sees …

News

WuXi PharmaTech borrows to expand

February 24, 2015
Manufacturing and Production, Sales and Marketing China, NextCODE Health, WuXi PharmaTech, XenoBiotic Laboratories, philadelphia

WuXi PharmaTech has kick started a syndicated loan arrangement in order to borrow up to $165 million from a consortium …

News
ronnie_meninger

Algatech gets new chief executive and chief scientist

February 24, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Algatech, Ronnie Meninger, Sammy Boussiba

Israel-based biotech Algatech has confirmed the appointment of Ronnie Meninger as its chief executive, and Sammy Boussiba as chief scientist. Meninger (pictured) …

Appointment
Merck image

Merck invests $450m in NGM Biopharma

February 23, 2015
Sales and Marketing Merck, NGM Biopharma, NP201, diabetes, nonalcoholic steatohepatitis, obesity

Merck is to collaborate on drug development with biotech firm NGM Pharmaceuticals in a $450 million deal. The collaboration will …

News
Pfizer image

Priority review for Pfizer’s lung drug

February 23, 2015
Sales and Marketing FDA, Pfizer, Rapamune, lung, lymphangioleiomyomatosis, sirolimus

The US Food and Drug Administration FDA has accepted Pfizer’s lung drug Rapamune for priority review. Rapamune (sirolimus) prevents organ …

News
Chiesi image

Chiesi’s stem cell therapy approved in Europe

February 23, 2015
Research and Development, Sales and Marketing Chiesi, EC, Europe, Holoclar, Holostem Advanced Therapies, LSCD, stem cell

Chiesi’s Holoclar has become the first stem cell therapy to get the green light in Europe, gaining conditional approval from …

News
Dementia image

UK government spends £300 million on dementia

February 23, 2015
Research and Development, Sales and Marketing Cameron, England, NHS, dementia, investment, research

UK prime minister David Cameron has said the government is to invest more than £300m into dementia research and that …

News
Valeant image

Valeant to buy Salix in $14.5 billion move

February 23, 2015
Sales and Marketing Deals, Heptares, Valeant, mergers, salix, sosei

Valeant has agreed a deal to acquire US-based speciality manufacturer of gastrointestinal drugs Salix in a move worth around $14.5 …

News
EU image

Act now – or risk running out of time for IDMP

February 23, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Eversheds, ISO, icsr, idmp, regulatory

Many people in pharma would argue that the world of regulatory compliance in the life sciences industry is already complicated …

Feature
anne_hyland

Kymab hires chief financial officer

February 23, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing anne hyland, kymab

Cambridge-based UK antibody development firm Kymab has appointed Anne Hyland as its chief financial officer.  Hyland takes to the firm …

Appointment
Boehringer image

Boehringer’s beer breach at German congress

February 20, 2015
Medical Communications, Sales and Marketing ABPI, Boehringer, ERS, IPF, PMCPA, breach, code, munich

A complaint made by a pulmonologist against the competence of Boehringer Ingelheim speakers during a congress held in Germany last …

News
screen_shot_2015-02-20_at_14

Chair appointed for new MHRA devices committee

February 20, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MHRA, Peter Nightingale, deac

Dr Peter Nightingale has been appointed as chairman of the Medicines and Healthcare products Regulatory Agency’s (MHRA) newly-formed Devices Expert …

Appointment
Mosquito image

Resistance threat to malaria drug is ‘alarming’

February 20, 2015
Research and Development, Sales and Marketing Africa, Qinghaosu, artemisinin, malaria, thailand

Resistance to a group of drugs that possess the most rapid action against malaria – artemisinin, aka Qinghaosu ­– is …

News
GSK image

Official linked to GSK bribes facing prison

February 20, 2015
Sales and Marketing China, Deirdre Connelly, GSK, Jack Bailey, Novartis, bribes

A Chinese health official linked to the GSK bribery scandal has been sentenced to 19 years in prison. Huang Fenping, …

News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026